Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE

Mateos, MV; Dimopoulos, MA; Cavo, M; Suzuki, K; Knop, S; Doyen, C; Lucio, P; Nagy, Z; Pour, L; Grosicki, S; Crepaldi, A; Liberati, AM; Campbell, P; Yoon, SS; Iosava, G; Fujisaki, T; Garg, M; Iida, S; Bladé, J; Ukropec, J; Pei, H; Van Rampelbergh, R; Kudva, A; Qi, M; San-Miguel, J

Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE

journal contribution

posted on 2024-06-13, 15:01 authored by MV Mateos, MA Dimopoulos, M Cavo, K Suzuki, S Knop, C Doyen, P Lucio, Z Nagy, L Pour, S Grosicki, A Crepaldi, AM Liberati, P Campbell, SS Yoon, G Iosava, T Fujisaki, M Garg, S Iida, J Bladé, J Ukropec, H Pei, R Van Rampelbergh, A Kudva, M Qi, J San-Miguel

Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE

History

Journal

Clinical Lymphoma, Myeloma and Leukemia

Volume

21

Pagination

785-798

Location

Amsterdam, The Netherlands

Open access

Yes

Link to full text

http://www.clinical-lymphoma-myeloma-leukemia.com/article/S215226502100210X/pdf

ISSN

2152-2650

eISSN

2152-2669

Language

eng

Author URL

https://www.ncbi.nlm.nih.gov/pubmed/34344638

Publication classification

C1 Refereed article in a scholarly journal

Issue

11

Publisher

Elsevier

Usage metrics

Keywords

CD38 Clinical study Efficacy Frail Monoclonal antibody 3211 Oncology and carcinogenesis 3201 Cardiovascular medicine and haematology

Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE

History

Journal

Volume

Pagination

Location

Open access

Link to full text

ISSN

eISSN

Language

Author URL

Publication classification

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports